# LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

> clinical trial · VERIFIED · 2026-06-22

Status: RECRUITING · Sponsor: enGene, Inc. · Condition: Superficial Bladder Cancer

- Company: enGene, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04752722

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.